$NIMU
NON INVASIVE MONITORING SYSTEMS INC /FL/

2014 Q2 Form 10-Q Financial Statement

#000114420414037503 Filed on June 13, 2014

View on sec.gov

Income Statement

Concept 2014 Q2 2013 Q3 2013 Q2
Revenue $0.00 $50.00K $10.00K
YoY Change -100.0% 0.0% -80.0%
Cost Of Revenue $0.00 $30.00K $3.000K
YoY Change -100.0%
Gross Profit $0.00 $20.00K $7.000K
YoY Change -100.0% -60.0% -86.0%
Gross Profit Margin 40.0% 70.0%
Selling, General & Admin $73.00K $110.0K $100.0K
YoY Change -27.0% -31.25% -28.57%
% of Gross Profit 550.0% 1428.57%
Research & Development $0.00 $0.00 -$2.000K
YoY Change -100.0% -120.0%
% of Gross Profit 0.0% -28.57%
Depreciation & Amortization $1.000M $10.00K $2.000K
YoY Change 49900.0% -80.0%
% of Gross Profit 50.0% 28.57%
Operating Expenses $73.00K $110.0K $98.00K
YoY Change -25.51% -31.25% -38.75%
Operating Profit -$73.00K -$90.00K -$91.00K
YoY Change -19.78% -18.18% -17.27%
Interest Expense -$30.00K -$30.00K -$30.00K
YoY Change 0.0% 0.0% 50.0%
% of Operating Profit
Other Income/Expense, Net $0.00 $0.00
YoY Change -100.0% -100.0%
Pretax Income -$110.0K -$120.0K -$120.0K
YoY Change -8.33% -20.0% 9.09%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$105.0K -$120.0K -$123.0K
YoY Change -14.63% -20.0% 11.82%
Net Earnings / Revenue -240.0% -1230.0%
Basic Earnings Per Share
Diluted Earnings Per Share -$1.393K -$1.507K -$1.681K
COMMON SHARES
Basic Shares Outstanding 78.94M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2014 Q2 2013 Q3 2013 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $90.00K $300.0K $430.0K
YoY Change -79.07% 400.0% 616.67%
Cash & Equivalents $91.00K $296.0K $428.0K
Short-Term Investments
Other Short-Term Assets $10.00K $50.00K $0.00
YoY Change 66.67% -100.0%
Inventory $460.0K $462.0K $490.0K
Prepaid Expenses
Receivables $0.00 $0.00 $0.00
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $556.0K $805.0K $920.0K
YoY Change -39.57% 33.06% 48.39%
LONG-TERM ASSETS
Property, Plant & Equipment $1.000K $5.000K $10.00K
YoY Change -90.0% -54.55% 0.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $1.000K $5.000K $10.00K
YoY Change -90.0% -54.55% -50.0%
TOTAL ASSETS
Total Short-Term Assets $556.0K $805.0K $920.0K
Total Long-Term Assets $1.000K $5.000K $10.00K
Total Assets $557.0K $810.0K $930.0K
YoY Change -40.11% 31.49% 45.31%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $830.0K $750.0K $750.0K
YoY Change 10.67% 20.97% 36.36%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $0.00
YoY Change
Total Short-Term Liabilities $831.0K $758.0K $760.0K
YoY Change 9.34% -53.21% -54.22%
LONG-TERM LIABILITIES
Long-Term Debt $1.200M $1.200M $1.200M
YoY Change 0.0% 4.35%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $1.200M $1.200M $1.200M
YoY Change 0.0% 700.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $831.0K $758.0K $760.0K
Total Long-Term Liabilities $1.200M $1.200M $1.200M
Total Liabilities $2.031M $1.958M $1.960M
YoY Change 3.62% 10.62% 18.07%
SHAREHOLDERS EQUITY
Retained Earnings -$24.21M -$23.88M
YoY Change 2.17%
Common Stock $789.0K $789.0K
YoY Change 14.51%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.474M -$1.148M -$1.030M
YoY Change
Total Liabilities & Shareholders Equity $557.0K $810.0K $930.0K
YoY Change -40.11% 31.49% 45.31%

Cashflow Statement

Concept 2014 Q2 2013 Q3 2013 Q2
OPERATING ACTIVITIES
Net Income -$105.0K -$120.0K -$123.0K
YoY Change -14.63% -20.0% 11.82%
Depreciation, Depletion And Amortization $1.000M $10.00K $2.000K
YoY Change 49900.0% -80.0%
Cash From Operating Activities -$50.00K -$130.0K -$140.0K
YoY Change -64.29% 116.67% 1300.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000 550.0K
YoY Change -100.0% -100.0%
NET CHANGE
Cash From Operating Activities -50.00K -130.0K -140.0K
Cash From Investing Activities
Cash From Financing Activities 0.000 0.000 550.0K
Net Change In Cash -50.00K -130.0K 410.0K
YoY Change -112.2% 1200.0% -4200.0%
FREE CASH FLOW
Cash From Operating Activities -$50.00K -$130.0K -$140.0K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q3 us-gaap Liabilities
Liabilities
1958000 USD
CY2014Q2 us-gaap Common Stock Value
CommonStockValue
789000 USD
CY2013Q3 us-gaap Common Stock Value
CommonStockValue
789000 USD
CY2014Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
21931000 USD
CY2013Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
21927000 USD
CY2014Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-24210000 USD
CY2013Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-23880000 USD
CY2014Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-49000 USD
CY2014Q2 nimu Royalties And Other Receivables Net
RoyaltiesAndOtherReceivablesNet
0 USD
CY2013Q3 nimu Royalties And Other Receivables Net
RoyaltiesAndOtherReceivablesNet
1000 USD
CY2014Q2 us-gaap Inventory Net
InventoryNet
460000 USD
CY2013Q3 us-gaap Inventory Net
InventoryNet
462000 USD
CY2014Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5000 USD
CY2013Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
46000 USD
CY2014Q2 us-gaap Assets Current
AssetsCurrent
556000 USD
CY2013Q3 us-gaap Assets Current
AssetsCurrent
805000 USD
CY2014Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1000 USD
CY2013Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5000 USD
CY2014Q2 us-gaap Assets
Assets
557000 USD
CY2013Q3 us-gaap Assets
Assets
810000 USD
CY2014Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
827000 USD
CY2013Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
754000 USD
CY2014Q2 us-gaap Customer Deposits Current
CustomerDepositsCurrent
4000 USD
CY2014Q2 us-gaap Cash
Cash
91000 USD
CY2013Q3 us-gaap Cash
Cash
296000 USD
CY2014Q2 us-gaap Stockholders Equity
StockholdersEquity
-1474000 USD
CY2013Q3 us-gaap Stockholders Equity
StockholdersEquity
-1148000 USD
CY2014Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
557000 USD
CY2013Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
810000 USD
CY2013Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3000 USD
CY2014Q2 us-gaap Long Term Debt
LongTermDebt
1200000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
11000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4000 USD
CY2014Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
627500 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
75000 shares
CY2014Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
1200000 USD
CY2013Q3 us-gaap Customer Deposits Current
CustomerDepositsCurrent
4000 USD
CY2014Q2 us-gaap Liabilities Current
LiabilitiesCurrent
831000 USD
CY2013Q3 us-gaap Liabilities Current
LiabilitiesCurrent
758000 USD
CY2014Q2 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
1150000 USD
CY2013Q3 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
1150000 USD
CY2014Q2 us-gaap Other Long Term Notes Payable
OtherLongTermNotesPayable
50000 USD
CY2013Q3 us-gaap Other Long Term Notes Payable
OtherLongTermNotesPayable
50000 USD
CY2014Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1200000 USD
CY2013Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1200000 USD
CY2014Q2 us-gaap Liabilities
Liabilities
2031000 USD
CY2013Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-49000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;BACKGROUND-COLOR: transparent; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b><i>Use of Estimates.</i></b> The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) requires management to make estimates and assumptions, such as accounts receivable, warranty accrual, deferred taxes, and the input variables for stock based compensation as estimates, that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from these estimates.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
us-gaap Royalty Revenue
RoyaltyRevenue
1000 USD
CY2013Q2 us-gaap Revenues
Revenues
10000 USD
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.335
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
538750 shares
CY2014Q2 nimu Negative Working Capital
NegativeWorkingCapital
275000 USD
CY2014Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
9000 USD
CY2013Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
9000 USD
CY2014Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
451000 USD
CY2013Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
453000 USD
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
613750 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
-75000 shares
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
538750 shares
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
538750 shares
CY2014Q2 us-gaap Revenues
Revenues
0 USD
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0.400
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.326
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
0.326
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.326
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P1Y8M5D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P1Y8M5D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P1Y8M5D
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
4800 USD
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
4800 USD
CY2014Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
4800 USD
CY2014Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2013Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2014Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
78942423 shares
CY2013Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
78942423 shares
CY2014Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
78942423 shares
CY2013Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
78942423 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Description
ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription
Companys Common Stock as of the grant date or an exercise price of not less than 110% of the fair value for a 10% shareholder.
CY2010Q1 us-gaap Line Of Credit Facility Amount Outstanding
LineOfCreditFacilityAmountOutstanding
1000000 USD
CY2014Q2 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
1000000 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
16179950 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
16064950 shares
CY2014Q2 nimu Beneficial Ownership Percentage
BeneficialOwnershipPercentage
0.1 pure
CY2014Q2 us-gaap Line Of Credit Facility Amount Outstanding
LineOfCreditFacilityAmountOutstanding
1000000 USD
CY2013Q3 us-gaap Line Of Credit Facility Amount Outstanding
LineOfCreditFacilityAmountOutstanding
1000000 USD
CY2014Q2 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
465000 USD
CY2013Q3 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
366000 USD
CY2013Q2 us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
8000 USD
CY2014Q2 us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
9000 USD
us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
26000 USD
us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
27000 USD
CY2007Q3 us-gaap Manufacturing Costs
ManufacturingCosts
471000 USD
CY2007Q3 us-gaap Cost Of Utilities
CostOfUtilities
150000 USD
CY2007Q3 nimu Payments On Approval Of Product Prototype Concepts And Designs
PaymentsOnApprovalOfProductPrototypeConceptsAndDesigns
150000 USD
CY2014Q2 us-gaap Purchase Obligation
PurchaseObligation
13900000 USD
CY2013Q3 us-gaap Purchase Obligation
PurchaseObligation
13900000 USD
CY2014Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
115000 USD
CY2013Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
115000 USD
CY2014Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
114000 USD
CY2013Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
110000 USD
CY2013Q2 us-gaap Depreciation
Depreciation
2000 USD
CY2014Q2 us-gaap Depreciation
Depreciation
1000 USD
us-gaap Depreciation
Depreciation
4000 USD
us-gaap Depreciation
Depreciation
4000 USD
CY2013Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
10000 USD
CY2014Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
0 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
44000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
0 USD
CY2013Q2 us-gaap Royalty Revenue
RoyaltyRevenue
0 USD
CY2014Q2 us-gaap Royalty Revenue
RoyaltyRevenue
0 USD
us-gaap Royalty Revenue
RoyaltyRevenue
16000 USD
us-gaap Revenues
Revenues
60000 USD
us-gaap Revenues
Revenues
1000 USD
CY2013Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
3000 USD
CY2014Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
0 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
14000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
0 USD
CY2013Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
100000 USD
CY2014Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
73000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
336000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
231000 USD
CY2013Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
-2000 USD
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2014Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
0 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1000 USD
CY2013Q2 us-gaap Costs And Expenses
CostsAndExpenses
101000 USD
CY2014Q2 us-gaap Costs And Expenses
CostsAndExpenses
73000 USD
us-gaap Costs And Expenses
CostsAndExpenses
352000 USD
us-gaap Costs And Expenses
CostsAndExpenses
232000 USD
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-91000 USD
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-73000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-292000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-231000 USD
CY2013Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-32000 USD
CY2014Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-32000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-95000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-99000 USD
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
-123000 USD
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
-105000 USD
us-gaap Net Income Loss
NetIncomeLoss
-387000 USD
us-gaap Net Income Loss
NetIncomeLoss
-330000 USD
CY2013Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
71399000 shares
CY2014Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
78942000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
69526000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
78942000 shares
CY2013Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2014Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
11000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
4000 USD
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-16000 USD
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-1000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-13000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-2000 USD
nimu Increase Decrease In Prepaid Expenses Deposits And Other Current Assets
IncreaseDecreaseInPrepaidExpensesDepositsAndOtherCurrentAssets
-28000 USD
nimu Increase Decrease In Prepaid Expenses Deposits And Other Current Assets
IncreaseDecreaseInPrepaidExpensesDepositsAndOtherCurrentAssets
-41000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
136000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
73000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-179000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-205000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
372000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-205000 USD
CY2012Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
56000 USD
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
296000 USD
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
428000 USD
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
91000 USD
nimu Transfer Of Tooling And Equipment To Inventory
TransferOfToolingAndEquipmentToInventory
1000 USD
nimu Transfer Of Tooling And Equipment To Inventory
TransferOfToolingAndEquipmentToInventory
0 USD
dei Document Type
DocumentType
10-Q
dei Amendment Flag
AmendmentFlag
false
dei Document Period End Date
DocumentPeriodEndDate
2014-04-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
dei Trading Symbol
TradingSymbol
NIMU
CY2014Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
78942423 shares
dei Entity Registrant Name
EntityRegistrantName
NON INVASIVE MONITORING SYSTEMS INC /FL/
dei Entity Central Index Key
EntityCentralIndexKey
0000720762
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--07-31
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
50000 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
551000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
501000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2014Q2 us-gaap Accounts Payable Related Parties Current And Noncurrent
AccountsPayableRelatedPartiesCurrentAndNoncurrent
3000 USD
CY2013Q3 us-gaap Accounts Payable Related Parties Current And Noncurrent
AccountsPayableRelatedPartiesCurrentAndNoncurrent
49000 USD
CY2013Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-123000 USD
CY2014Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-105000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-387000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-330000 USD

Files In Submission

Name View Source Status
0001144204-14-037503-index-headers.html Edgar Link pending
0001144204-14-037503-index.html Edgar Link pending
0001144204-14-037503.txt Edgar Link pending
0001144204-14-037503-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
nimu-20140430.xml Edgar Link completed
nimu-20140430.xsd Edgar Link pending
nimu-20140430_cal.xml Edgar Link unprocessable
nimu-20140430_def.xml Edgar Link unprocessable
nimu-20140430_lab.xml Edgar Link unprocessable
nimu-20140430_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v381125_10q.htm Edgar Link pending
v381125_ex31-1.htm Edgar Link pending
v381125_ex31-2.htm Edgar Link pending
v381125_ex32-1.htm Edgar Link pending
v381125_ex32-2.htm Edgar Link pending